The National Gallery
estrace tablets dosage
Omnivision Technologies Inc slumped 13.2 percent to$15.99 after the chipmaker forecast current-quarter adjustedprofit largely below expectations as rising competition and aslowdown of U.S. smartphone sales led to an inventory pile-up.